02/19/2025 3:57 PM | Kiromic BioPharma (Filer)
| Form S-1/A | |
02/03/2025 3:11 PM | Kiromic BioPharma (Filer)
| Form 8-K/A | |
02/03/2025 10:10 AM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/17/2025 4:30 PM | Kiromic BioPharma (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/11/2024 3:32 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 1:51 PM | Kiromic BioPharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024 6:38 PM | Kiromic BioPharma (Subject) YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
09/30/2024 3:29 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/26/2024 5:44 PM | BERSANI PIETRO (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 2:04 PM | Kiromic BioPharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/09/2024 7:01 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KRBP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kiromic BioPharma and its competitors with MarketBeat's FREE daily newsletter.
|
06/28/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2024 4:21 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 5:32 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:30 PM | Hungerford Brian (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:35 PM | BERSANI PIETRO (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:36 PM | Hungerford Brian (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:36 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:37 PM | Kiromic BioPharma (Issuer) NAGEL MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 4:00 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 5:29 AM | Kiromic BioPharma (Filer)
| Form ARS | |
05/20/2024 5:29 AM | Kiromic BioPharma (Filer)
| Form ARS | |
05/10/2024 9:37 AM | Kiromic BioPharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 4:29 PM | Kiromic BioPharma (Issuer) Mirandola Leonardo (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/09/2024 4:00 PM | BERSANI PIETRO (Filed by) Kiromic BioPharma (Subject)
| Form SC 13D/A | |
05/07/2024 5:17 PM | Hungerford Brian (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 4:30 PM | Kiromic BioPharma (Filer)
| Form PRE 14A | |
05/07/2024 4:00 PM | BERSANI PIETRO (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/06/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form RW | |
04/05/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 4:21 PM | Kiromic BioPharma (Filer)
| Form 10-K/A | |
03/20/2024 4:58 PM | Catlin Michael (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:55 PM | Kiromic BioPharma (Issuer) NAGEL MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:57 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |